SHA:603233 Market Cap

SHA:603233 has a market cap or net worth of 21.89 billion as of February 13, 2026. Its market cap has increased by 41.32% in one year.

Market Cap

21.89B

Enterprise Value

22.48B

Revenue

26.83B

Ranking

n/a

PE Ratio

19.00

Stock Price

19.22

Market Cap Chart

Since July 31, 2017, SHA:603233's market cap has increased from 14.24B to 21.89B, an increase of 53.71%. That is a compound annual growth rate of 5.16%.

Market Cap History

Date	Market Cap	% Change
Feb 13, 2026	21.89B	9.08%
Dec 31, 2025	20.07B	17.00%
Dec 31, 2024	17.15B	-39.52%
Dec 29, 2023	28.36B	-24.55%
Dec 30, 2022	37.59B	12.85%
Dec 31, 2021	33.31B	-35.46%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Jul 31, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Beijing Tiantan Biological Products	32.63B
Xiamen Amoytop Biotech	29.80B
Hualan Biological Engineering	28.29B
Suzhou Zelgen Biopharmaceuticals	25.62B
Yili Chuanning Biotechnology	25.27B
BrightGene Bio-Medical Technology	19.51B
Inner Mongolia Furui Medical Science	18.22B
Sinocelltech Group	18.00B

Market Cap Rankings